RxDoctor Payments Data

Joseph Jackson, MD

Family Medicine · Albany, GANPI 1811980352

Payments from drug & device makers

$4,781in general payments, 2019–2025

Across 241 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$842
  • AbbVie$637
  • Novo Nordisk$575
  • Organogenesis Inc.$512
  • Amgen$469
  • AstraZeneca$243
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,74299%
  • Education$391%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,781 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$224,965
Medicare patients
775
Services billed
5,971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin159$169,229
OzempicSemaglutide125$146,055
EliquisApixaban137$128,923
MounjaroTirzepatide79$98,787
FarxigaDapagliflozin Propanediol67$79,121
TrulicityDulaglutide43$53,713
JanuviaSitagliptin Phosphate39$35,992
ArexvyRsvpref3 Antigen/As01e/Pf118$34,395
Synjardy XrEmpagliflozin/Metformin Hcl32$32,919
MyrbetriqMirabegron43$31,363
XareltoRivaroxaban36$27,887
LinzessLinaclotide24$27,567
RybelsusSemaglutide15$25,444
ShingrixVaricella-Zoster Ge/As01b/Pf101$20,818
TradjentaLinagliptin15$18,562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Jentadueto$63$234,686221 claims
Novo NordiskOzempic, Rybelsus$575$171,499140 claims
Lilly USA, LLCMounjaro, Trulicity$57$152,500122 claims
PfizerEliquis$68$128,923137 claims
AstraZenecaFarxiga$243$79,12167 claims
GSKArexvy, Shingrix, Trelegy Ellipta$41$70,884238 claims
AbbVieLinzess, Synthroid$637$31,44470 claims
Astellas Pharma US IncMyrbetriq$842$31,36343 claims
Johnson & JohnsonXarelto$225$27,88736 claims
BayerKerendia$39$17,08324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Albany

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →